[go: up one dir, main page]

NZ744238B2 - Fermented formula with non-digestible oligosaccharides - Google Patents

Fermented formula with non-digestible oligosaccharides

Info

Publication number
NZ744238B2
NZ744238B2 NZ744238A NZ74423816A NZ744238B2 NZ 744238 B2 NZ744238 B2 NZ 744238B2 NZ 744238 A NZ744238 A NZ 744238A NZ 74423816 A NZ74423816 A NZ 74423816A NZ 744238 B2 NZ744238 B2 NZ 744238B2
Authority
NZ
New Zealand
Prior art keywords
oligosaccharide
nutritional composition
lactic acid
use according
fermented
Prior art date
Application number
NZ744238A
Other versions
NZ744238A (en
Inventor
Houkje Bouritius
Jan Knol
Alma Jildou Nauta
Akhtar Raish Oozeer
Original Assignee
Nv Nutricia
Filing date
Publication date
Application filed by Nv Nutricia filed Critical Nv Nutricia
Publication of NZ744238A publication Critical patent/NZ744238A/en
Publication of NZ744238B2 publication Critical patent/NZ744238B2/en

Links

Abstract

fermented formula comprising non digestible oligosaccharides synergistically stimulates secretory IgA in infants. In particular, the invention provides the use of a composition comprising 0.02-1.5 wt% lactic acid bacteria and lactate combined, produced from a fermented lactic acid bacteria and 2.5-15 wt% non-digestible oligosaccharides to increase IgA secretion and improve mucosal immune defense in infants or babies.

Claims (13)

WHAT WE CLAIM IS:
1. Use of a fermented ingredient and gestible oligosaccharide in the manufacture of a nutritional composition for preventing or treating a disorder that is prevented or treated by increasing IgA secretion in a human subject with an age of 0 to 36 months, wherein the fermented ingredient is a composition that is fermented by lactic acid producing bacteria and wherein the ional composition comprises 0.02 to 1.5 wt% of the sum of lactic acid and lactate based on dry weight of the nutritional composition and comprises 2.5 to 15 wt% non-digestible oligosaccharide based on dry weight of the nutritional composition.
2. Use of a fermented ingredient and non-digestible oligosaccharide in the manufacture of a nutritional composition for use in improving l immune defense in a human subject with an age of 0 to 36 months, wherein the fermented ingredient is a ition that is ted by lactic acid producing bacteria and wherein the nutritional composition comprises 0.02 to 1.5 wt% of the sum of lactic acid and lactate based on dry weight of the nutritional composition and comprises 2.5 to 15 wt% nondigestible oligosaccharide based on dry weight of the nutritional composition.
3. The use according to any one of the preceding claims wherein the fermented ingredient is a milk substrate that is fermented by lactic acid producing bacteria, and said milk ate comprises at least one selected from the group consisting of milk, whey, whey protein, whey protein hydrolysate, casein, casein hydrolysate, and lactose or mixtures thereof.
4. The use ing to any one of the preceding claims, wherein the nutritional composition is an infant formula, a follow on formula or a g up milk.
5. The use according to any one of the preceding claims, wherein the gestible oligosaccharide is selected from the group consisting of fructo-oligosaccharide, non- digestible dextrin, galacto-oligosaccharide, xylo-oligosaccharide, arabinooligosaccharide , ogalacto-oligosaccharide, gluco-oligosaccharide, gentiooligosaccharide , glucomanno-oligosaccharide, galactomanno-oligosaccharide, mannan-oligosaccharide, isomalto-oligosaccharide, nigero-oligosaccharide, glucomanno-oligosaccharide, chito-oligosaccharide, soy oligosaccharide, uronic acid oligosaccharide, sialyloligosaccharide, and fuco-oligosaccharide, and mixtures thereof.
6. The use ing to any one of the preceding , wherein the non-digestible oligosaccharide comprises galacto-oligosaccharide and/or fructo-oligosaccharide.
7. The use according to any one of the preceding claims, wherein at least 90 wt% of the sum of lactic acid and lactate is L(+)-lactic acid and/or L(+)-lactate.
8. The use according to any one of the preceding claims, wherein the fermented ingredient is fermented by Bifidobacterium and/or ococcus.
9. The use according to any one of the preceding claims n the nutritional composition comprises Bifidobacterium breve and/or ococcus thermophilus.
10. The use according to any one of the preceding claims wherein the lactic acid producing bacteria are inactivated to a level below 105, more preferably below 103 cfu/g dry weight of the nutritional composition.
11. The use according to any one of the preceding claims wherein the nutritional composition comprises protein, digestible carbohydrate and lipid and wherein the protein provides 1.6 to 4 g per 100 kcal, the digestible carbohydrates provides 5 to 20 g per 100 kcal and the lipid es 3 to 7 g lipid per 100 kcal of the nutritional composition.
12. Use according to claim 1, substantially as herein described or ified.
13. Use according to claim 2, substantially as herein described or exemplified.
NZ744238A 2016-12-29 Fermented formula with non-digestible oligosaccharides NZ744238B2 (en)

Publications (2)

Publication Number Publication Date
NZ744238A NZ744238A (en) 2025-01-31
NZ744238B2 true NZ744238B2 (en) 2025-05-01

Family

ID=

Similar Documents

Publication Publication Date Title
Walton et al. Mechanisms linking the human gut microbiome to prophylactic and treatment strategies for COVID-19
CN102123715B (en) Nutrients that Stimulate the Immune System
Jeurink et al. Mechanisms underlying immune effects of dietary oligosaccharides
CN101400267B (en) Oligosaccharide mixture
US11998030B2 (en) Non-dairy drink with rice and pea proteins
US9005682B2 (en) Synbiotic mixture
Lara-Villoslada et al. Beneficial effects of probiotic bacteria isolated from breast milk
AU2012260945B2 (en) Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides, and a process to produce the composition
RU2015100867A (en) ACID-MILK MIXTURE FOR BREAST CHILDREN WITH UNDIGABLE OLIGOSACCHARIDES
US9498502B2 (en) Prevention and treatment of allergic diarrhea
RU2018127650A (en) Fermented milk mixture with indigestible oligosaccharides
CN118632706A (en) Compositions comprising osteopontin (OPN)
NZ744238B2 (en) Fermented formula with non-digestible oligosaccharides
NZ744238A (en) Fermented formula with non-digestible oligosaccharides
US20160206658A1 (en) Nutrition for prevention of infections
Bengmark Synbiotics in human Medicine
RU2833704C2 (en) Use of non-dairy beverage with rice and pea proteins for feeding babies with cow protein allergy
HK1261683A1 (en) Fortified milk-based nutritional compositions